Posts in LSE:TSTL

This FTSE 100 share isn’t the only healthcare stock on my shopping list

NMC Health (LSE:NMC) may not be the best known FTSE 100 healthcare giant. But I am convinced that its presence in the lucrative Middle East, built by a steady raft of acquisitions, allied with its plans to expand its presence into other emerging markets, makes it no less compelling as growth pick than GlaxoSmithKline or AstraZeneca.

Tristel profit rises on overseas expansion

Infection control product manufacturer Tristel posted a rise in first-half profit after it boosted overseas sales.

Pre-tax profit rose 8.7% to £1.85m, as revenue rose 10% to £10.7m and overseas sales rose 28%.

The company declared an interim dividend of 1.6p per share, up from 1.4p in 2016.

'We are progressing steadily with our planned entry into the North American hospital market having satisfied the additional data requirements of the EPA,' chief executive Paul Swinney said.

'A decision is expected from the EPA during the second half of this financial year.

Broker Forecast - finnCap issues a broker note on Tristel PLC

finnCap today reaffirms its corporate investment rating on Tristel PLC (LON:TSTL) and raised its price target to 280p (from 275p).

Broker Forecasts data provided by

10 high quality growth stocks that rode out the market dip

10 high quality growth stocks that rode out the market dip

Stockopedia's Ben Hobson takes a look at an essential investment template for the small-cap investor.

2 small-cap growth stocks I’m watching closely

People often ask me what it takes to be a good investor, and my answer is always the same. Along with a whole range of skills and personality traits, I believe the most important virtue of all is patience.

Tristel forecasts 1H profit growth

Tristel said it expected to report a rise in first-half profit as the company continues to perform in line with management expectations.

The group expects its unaudited pre-tax profit to be no less than £1.9m, compared to £1.7m a year earlier, chief executive Paul Swinney said in speech notes for the company's annual general meeting.

The company's unaudited interim results will be announced on February 20.

15 stocks in the 'buy zone'

15 stocks in the 'buy zone'

After rejigging the algorithm and reassessing every share ranked by his Decision Engine stock screener, companies analyst Richard Beddard has a lot to report on.

Share Sleuth: Be wary of excessive executive pay

Share Sleuth: Be wary of excessive executive pay

When shareholders wave through share option remuneration packages, executives can cash in without doing the solid work needed. Richard Beddard issues a warning.

Tristel issues shares

Tristel has confirmed that the Company issued 116,950 new shares following the exercise of options by an employee.

At 2:04pm: (LON:TSTL) Tristel PLC share price was 0p at 280p

Is superstar Tristel unbeatable?

Is superstar Tristel unbeatable?

It's dominated one market, could dominate others, is debt free, highly profitable, growing, and has competitive advantages, but analyst Richard Beddard is getting cold feet.